Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
EMD Serono
EMD Serono
Novartis
Revolution Medicines, Inc.
Faeth Therapeutics
AstraZeneca
Incyte Corporation
Actuate Therapeutics Inc.
Novartis
EMD Serono
Aadi Bioscience, Inc.
Incyte Corporation
Pfizer
Pfizer